DLA Piper has advised Vanessa Research and its Hungarian subsidiary on a change of ownership and company structure. The sell-side of the transaction was reportedly advised by Zsolt Szita and Lanchidi & Partners.
According to DLA Piper, the parties have agreed not to disclose the new ownership and company structure nor the financial details of the transaction.
Vanessa Research is a US-based biomedical company that, it reports, “seeks to make an impact on often overlooked healthcare markets.”
DLA Piper’s Hungary-based team included Partner Gabor Molnar and Senior Associate Gabor Spitz.
